Growth Metrics

GeneDx Holdings (WGS) Consolidated Net Income: 2020-2025

Historic Consolidated Net Income for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to -$7.6 million.

  • GeneDx Holdings' Consolidated Net Income rose 8.14% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 102.50%. This contributed to the annual value of -$52.3 million for FY2024, which is 70.25% up from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Consolidated Net Income is -$7.6 million, which was down 170.64% from $10.8 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Consolidated Net Income registered a high of $32.7 million during Q3 2021, and its lowest value of -$308.7 million during Q4 2022.
  • Over the past 3 years, GeneDx Holdings' median Consolidated Net Income value was -$20.2 million (recorded in 2024), while the average stood at -$21.0 million.
  • As far as peak fluctuations go, GeneDx Holdings' Consolidated Net Income soared by 157.81% in 2021, and later plummeted by 668.23% in 2022.
  • Over the past 5 years, GeneDx Holdings' Consolidated Net Income (Quarterly) stood at -$40.2 million in 2021, then crashed by 668.23% to -$308.7 million in 2022, then skyrocketed by 91.65% to -$25.8 million in 2023, then soared by 121.10% to $5.4 million in 2024, then increased by 8.14% to -$7.6 million in 2025.
  • Its Consolidated Net Income was -$7.6 million in Q3 2025, compared to $10.8 million in Q2 2025 and -$6.5 million in Q1 2025.